Deep Dive In Vitiligo

In this World Vitiligo Day 2026 Special, we explore the raw territory where autoimmune disease, chronic stress, ancient traditions, and modern science collide. From karma and samskaras in India to ayahuasca ceremonies deep in the Amazon, from Bakuchi in Ayurveda to T-cells and JAK inhibitors, we examine how cultures across time have tried to explain — and heal — vitiligo. Inside the episode: - Why...

What if the modern vitiligo movement began decades earlier than most people realize? In this episode, we travel back nearly 50 years to explore one of the most forgotten chapters in vitiligo history: the National Vitiligo Control Act. Long before social media, celebrity advocates, World Vitiligo Day, or FDA-approved treatments, a small group of advocates was already trying to bring vitiligo into t...

Is your sunscreen doing more harm than good? UV protection is non-negotiable — especially when your depigmented skin has zero natural melanin shield — but FDA absorption studies, benzene recalls, and endless headlines have turned a simple tool into a source of anxiety. We cut through the fog: chemical vs. mineral realities, why chasing SPF 100 often backfires, and how to protect yourself smartly w...

The cavalry has finally arrived — but now you need a map. In this fast-paced Deep Dive in Vitiligo briefing, VRF CEO Yan Valle explores the forces reshaping the vitiligo landscape—from pharmaceutical giants and emerging biotech companies to AI-powered research, teledermatology, and the growing role of India and China in global innovation. Inside this episode: The Pioneers vs. The Giants: How a han...

Discover the extraordinary, little-known story behind World Vitiligo Day, observed every year on June 25. In this episode, we unpack the remarkable rise of World Vitiligo Day (WVD). Based on the comprehensive retrospective by the Vitiligo Research Foundation, we explore the grassroots efforts of advocates in India, the United States, and Nigeria, the unexpected role of Michael Jackson’s global fan...

The Jackson-Thomas-Harlow Effect describes how visibility, storytelling, and cultural representation can reshape public understanding of vitiligo. In this episode of Deep Dive in Vitiligo, we look at how: Michael Jackson made vitiligo globally known, Lee Thomas gave it a courageous and deeply human public voice, and Winnie Harlow helped turn visible difference into mainstream representation. We al...

Google sees billions of searches. But what if, for one day, it helped the world see vitiligo? In this episode of Deep Dive in Vitiligo, we explore the renewed campaign to bring a Google Doodle to World Vitiligo Day on June 25, 2026. Past attempts did not succeed. This year, the strategy shifts from emotional appeals to raw tech logistics. We discuss how the vitiligo community is mobilizing for a c...

After a brief hiatus, the Deep Dive in Vitiligo podcast returns with a packed lineup of new episodes covering vitiligo science, lifestyle, advocacy, and technology. In this update, Yan Valle explains where the podcast has been, why AI didn’t save nearly as much time as promised, and what’s coming next—including the Jackson–Thomas–Harlow Effect children’s books coffee and red wine smoking and vapin...

In this closing 2025 episode, we unpack four decades of National Institute of Health (NIH) data, compare vitiligo’s budget to other autoimmune and skin diseases, and explain the “industry twist”: tiny public dollars helped build the science, while the commercial market is now booming. We also look at the big paradox: vitiligo research helped spark major ideas in modern medicine (think immune pathw...

In this year-end episode, we walk through what VRF built in 2025 — from global advocacy and new research to education, AI support tools, and community partnerships — plus the uncomfortable truths that shaped our priorities for 2026. Read the full report here: https://vrfoundation.org/news_items/vr-foundation-2025-year-end-report

Vitiligo may show up on your skin, but the drama starts lower down — in your gut, where trillions of microbes run the show. When that microscopic circus gets out of tune, your immune system can lose its mind. Enter sucralose — that “harmless” fake sugar in your diet soda and protein shake. It tastes sweet, promises zero calories, and might just be quietly gaslighting your gut bacteria. The result?...

From Easter Island soil to modern skin science — meet rapamycin, the molecule that might just change vitiligo care. Once known mainly as an anti-rejection drug for organ transplants, rapamycin is now being tested as a topical treatment that could both calm the immune attack and help pigment return. Early studies look promising: minimal side effects, slow but steady repigmentation, and surprisingly...

Vitiligo isn’t just skin deep — it’s a full-body story. Almost half of those living with it also face anxiety or depression, tied together by the same stress circuits that link the brain and the skin. In this episode, we dive into how antidepressants affect both body and mind — and why that matters for vitiligo care. You’ll hear: How stress hormones can trigger or worsen pigment loss What The Lanc...

What happens when a diagnosis becomes a movement? In this episode, we follow vitiligo’s unlikely journey from clinic charts to concert stages — a story painted in art, music, film, and unapologetic self-expression. From rickshaw parades in Chandigarh to AI-generated portraits in Toronto and a wax figure at Madame Tussauds New York, creativity has become the heartbeat of World Vitiligo Day. You’ll...

When we launched vitiligo.ai back in 2023, the idea was simple: make reliable information about vitiligo available to anyone, anywhere, in any language. What could possibly go wrong, right? Fast forward two years — turns out AI can sound smart, act caring, and still be utterly clueless. It imitates empathy but doesn’t actually care. It oozes confidence but often has no idea what it’s talking about...

This one’s long overdue — but too important to ignore. On May 24, 2025, the World Health Organization finally looked up from its stack of pandemics and cholesterol charts and said, “Oh right — skin diseases exist.” They’re now officially a global public health priority. Took only 2 billion people and a few decades of collective itching, burning, and patching to get there. In this episode, we break...

Vitiligo has always had a delivery problem. Creams can’t get past the skin’s outer “brick wall,” and systemic drugs hit the whole body. Now, nanotechnology is changing that — turning microscopic carriers into smart delivery trucks that sneak medicine exactly where it’s needed. In this episode: Why most creams fail to reach pigment cells How nano-formulations like liposomal khellin and ethosomal ps...

Let’s be honest — when vitiligo hits your hands, there’s no hiding it. You notice. Everyone notices. And that’s what makes it one of the toughest forms to live with — and to treat. The good news? A new study out of Osaka University finally gives this problem some structure. For the first time, scientists mapped out four clear subtypes of hand vitiligo — from small scattered patches in kids to full...

Forget everything you thought you knew about vitiligo. In this episode, we explore a groundbreaking new classification that shifts the focus from where vitiligo appears to how it behaves — offering doctors and patients a smarter, more predictive framework for care. Ditch the old “segmental vs. non-segmental” divide. Meet five real-world phenotypes: Highly Active Vitiligo Patches that spread quickl...

That 2 p.m. crash isn’t just about carbs, boredom, or Netflix binges. A sweeping new study of 6,000 people shows your blood chemistry — the hormones, fats, and even last night’s cheese board — may be scripting your afternoon slump. In this episode, we unpack the seven molecules linked to daytime sleepiness, from omega fatty acids that keep you sharp to tyramine (hello, wine and parmesan) that make...

What does vitiligo care really cost in America today? From dermatology consults and phototherapy sessions to prescription creams like Opzelura, the bills can pile up fast. In this episode, we unpack the true 2025 price tag of vitiligo treatment in the U.S., how much insurance actually covers, and the out-of-pocket traps patients often face. Plus: practical tips to stretch coverage, navigate copay...

Vitiligo care is finally breaking free from the old routine of steroids and phototherapy. Biologics like JAK inhibitors are driving impressive repigmentation in trials, while ruxolitinib cream made history as the first FDA-approved topical. But the real headline is safety. A decade of FDA reports on tacrolimus, pimecrolimus, and ruxolitinib shows mostly mild, local side effects — yet a few rare su...

Today, we take you behind the scenes of something rare: a tour inside Incyte’s research labs in Wilmington, Delaware, followed by the Patient Advocacy Summit. Day One (September 4, 2025) felt almost cinematic — community leaders walking the same halls as scientists, asking everything from “What does it take to become a scientist?” to “How do you decide which molecule deserves millions in investmen...

What really causes vitiligo? Genes, autoimmunity, stress… yes. But research now suggests where you live could matter just as much. A major new study links environmental chemicals — especially phenols from industry and household products — to striking vitiligo “hotspots” across the U.S., including Massachusetts, the Rust Belt, and the Midwest. In this episode, we take on one of the toughest questio...

Curious about the future of vitiligo treatment? We take an investor-grade tour of the pipeline—breaking down leading mechanisms (JAK/TYK2, immune modulation, melanocyte regeneration), late- vs. early-stage assets, pivotal readouts, safety themes, and regional access. We also track pricing and reimbursement signals, partnerships and M&A to watch, and what it all means for clinics, patients, and...